Skip to main content
Clinical Trials/NCT06767475
NCT06767475
Enrolling By Invitation
Not Applicable

Effectiveness of Mindfulness-Based Intervention on Patient Reported Outcomes of Black Adult Cancer Survivors: A Community Faith-based Mindfulness Ministry (ComFaMM) Trial

Mayo Clinic1 site in 1 country115 target enrollmentDecember 31, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hematopoietic and Lymphatic System Neoplasm
Sponsor
Mayo Clinic
Enrollment
115
Locations
1
Primary Endpoint
Spiritual well-being
Status
Enrolling By Invitation
Last Updated
11 months ago

Overview

Brief Summary

This clinical trial evaluates the impact of a Mindfulness-Based Stress Reduction (MBSR) program adjusted to include Christian principles on well-being in Black adult cancer survivors. Cancer survivors face a unique set of challenges that includes not only physical but also mental and spiritual well-being. Concerns related to both diagnosis and treatment profoundly impact the quality of life of Black cancer survivors. Mindfulness-based interventions (MBIs) have been shown to be effective in improving psychological resilience, reducing anxiety, and enhancing the quality of life among cancer survivors. However, there is little research focusing on these interventions among Black adult cancer survivors. Research has shown that interventions that include cultural experiences, such as the role of religion, spirituality and faith, are more effective in maintaining psychological well-being in Black men. A MBSR program adjusted to include Christian principles may improve the well-being in Black adult cancer survivors.

Detailed Description

PRIMARY OBJECTIVES: I. Develop a culturally adapted Mindfulness-Based Stress Reduction (MBSR) intervention. (Phase 0) II. Pilot test the MBSR intervention to assess its feasibility, acceptability, and preliminary efficacy among a small group of participants. (Phase 0) OUTLINE: PHASE 0: INTERVENTION DEVELOPMENT: Participants attend a focus group or a one-on-one interview over up to 60 minutes to gather insights of the cultural needs of Black adult cancer survivors. PILOT TESTING: Patients participate in a group discussion with exercises and activities on study. After completion of study intervention, patients are followed up at 3 months. PHASE 1: Patients participate in group discussions, exercises, and activities over no more than 8 hours for up to 3 sessions (up to 16 hours total) within 8 weeks. PHASE 2: Patients are randomized to 1 of 2 groups. GROUP I (INTERVENTION): Patients participate in group discussions, exercises, and activities over no more than 8 hours for up to 3 sessions (up to 16 hours total). GROUP II (CONTROL): Patients receive usual care on study. After completion of study intervention, patients are followed up at 3 and 6 months.

Registry
clinicaltrials.gov
Start Date
December 31, 2024
End Date
December 31, 2028
Last Updated
11 months ago
Study Type
Interventional
Study Design
Sequential
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Floyd B. Willis, MD

Principal Investigator

Mayo Clinic

Eligibility Criteria

Inclusion Criteria

  • PHASE 0 DEVELOPMENT: Adults aged 18 or older
  • PHASE 0 DEVELOPMENT: Ability to speak, read and understand English
  • PHASE 0 DEVELOPMENT: Individuals personally affected by cancer, either through their own diagnosis or that of a loved one
  • PHASE 0 DEVELOPMENT: Self-identifies as Black or African American
  • PHASE 0 DEVELOPMENT: Membership or affiliation with a faith-based organization
  • PHASE 0 PILOT TESTING: Adults aged 18 or older
  • PHASE 0 PILOT TESTING: History of a cancer diagnosis
  • PHASE 0 PILOT TESTING: Meets National Cancer Institute (NCI) cancer survivor definition (a person is a survivor from the time of diagnosis until the end of life)
  • PHASE 0 PILOT TESTING: Ability to physically attend live MBI and complete web-based surveys and assessments
  • PHASE 0 PILOT TESTING: Ability to speak, read and understand English

Exclusion Criteria

  • PHASE 0 DEVELOPMENT: Does not meet the inclusion criteria
  • PHASE 0 DEVELOPMENT: Unable or unwilling to participate in the recorded sessions
  • PHASE 0 PILOT TESTING: Inability to attend and participate in MBI due to medical or psychological hardship
  • PHASE 0 PILOT TESTING: Inability to speak, read and understand English
  • PHASE 1: Inability to attend and participate in MBI due to medical or psychological hardship
  • PHASE 1: Inability to speak, read and understand English
  • PHASE 1: Participated in phase 0 of the study
  • PHASE 2: Inability to attend and participate in MBI due to medical or psychological hardship
  • PHASE 2: Inability to speak, read and understand English
  • PHASE 2: Participated in phase 0 or phase 1 of the study

Outcomes

Primary Outcomes

Spiritual well-being

Time Frame: Up to 3 months

Will be measured by the change in scores on the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being Scale (FACIT-Sp-12). The FACIT-Sp-12a is a 12-item scale measuring spiritual well-being over the past 7 days. Responses are on a 5 point Likert-type scale (0=not at all; 1=a little bit, 2=somewhat; 3=quite a bit; 4=very much) with higher scores generally representing greater well-being

Secondary Outcomes

  • Quality of life (QOL)(Up to 3 months)
  • Level of resilience - CD-RISC(Up to 3 months)
  • Level of resilience - RSA(Up to 3 months)
  • Personal spirituality and closeness with God(Up to 3 months)
  • Overall assessment of the MBI and perception of MBI value(3 months)

Study Sites (1)

Loading locations...

Similar Trials